台股 » 個股 » 智擎 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智擎

(4162)
可現股當沖
  • 股價
    96.1
  • 漲跌
    ▲0.9
  • 漲幅
    +0.95%
  • 成交量
    522
  • 產業
    上櫃 生技醫療類股
  • 306人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
智擎 (4162)籌碼相關-台中銀 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

台中銀 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/17195.6000.0093.2011,3640.07%
2025/01/15193.1000.0093.1011,3800.07%
2025/01/1400.00197.2096.10-11,372-0.07%
2025/01/10196.4000.0097.0011,3550.07%
2025/01/0600.00199.90101.50-11,259-0.08%
2025/01/0200.00194.8093.60-11,235-0.08%
2024/12/300.591.7800.0091.000.51,2240.04%
2024/12/270.392.5900.0092.000.31,2230.02%
2024/12/260.292.1700.0092.500.21,2250.02%
2024/12/0600.00193.5093.30-11,180-0.08%
2024/11/29197.8000.0097.5011,1360.09%
2024/11/2200.00195.7093.80-11,031-0.10%
2024/11/2100.00197.6096.20-11,021-0.10%
2024/11/20097.30296.3096.50-21,018-0.19%
2024/11/062106.2500.00102.5028260.24%
2024/11/0500.001106.00106.00-1782-0.13%
2024/11/043100.671100.50100.0027580.26%
2024/11/011109.5000.00105.0017300.14%
2024/10/301100.502101.00102.00-1617-0.16%
2024/10/282101.502100.85102.0005760.00%
2024/10/2500.00198.7097.40-1513-0.19%
2024/10/24198.20199.7098.3004940.00%
2024/10/23193.1000.0093.7014240.24%
2024/10/18187.8000.0086.8014500.22%
2024/10/1500.00190.0090.20-1483-0.21%
2024/10/09189.5000.0089.5015080.20%
2024/09/3000.00190.0089.50-1550-0.18%
2024/09/13182.10182.4082.2006440.00%
2024/09/1000.00183.4083.30-1662-0.15%
2024/08/21186.6000.0086.6017460.13%
2024/08/15184.5000.0084.5017450.13%
2024/08/0900.00187.3085.40-1783-0.13%
2024/08/0700.00186.7086.70-1794-0.13%
2024/08/06380.30180.3080.8027830.26%
2024/07/29196.10195.4094.5007360.00%
2024/07/2600.00196.9097.60-1729-0.14%
2024/07/19397.00199.7094.2027080.28%
2024/07/1800.00299.0099.40-2676-0.30%
2024/07/16197.2000.0097.0016580.15%
2024/07/1500.001198.5598.40-11663-1.66%
2024/07/11295.8500.0095.2026500.31%
2024/07/0800.008100.38100.50-8655-1.22%
2024/07/0500.00497.1097.50-4625-0.64%
2024/07/04196.3000.0096.0016260.16%
2024/07/03196.4000.0096.7016280.16%
2024/07/02698.67898.2097.80-2623-0.32%
2024/06/28196.10197.0097.5005810.00%
2024/06/2700.001297.3095.70-12582-2.06%
2024/06/2600.00596.7897.60-5576-0.87%
2024/06/24593.2200.0093.2055890.85%
2024/06/21494.25294.9593.7026070.33%
2024/06/20694.3700.0094.5066350.94%
2024/06/19194.9000.0093.8016370.16%
2024/06/17195.3000.0095.5016440.16%
2024/06/1300.001097.3096.90-10651-1.54%
2024/06/111096.0000.0095.40106361.57%
2024/06/05490.85192.9092.9036320.47%
2024/06/04491.2500.0090.8046470.62%
2024/05/2700.00191.4091.70-1776-0.13%
2024/05/2400.00193.1092.80-1808-0.12%
2024/05/22295.4000.0094.1028470.24%
2024/05/21196.40195.5095.1008500.00%
2024/05/20298.35196.9096.9018650.12%
2024/05/17397.23498.6397.90-1872-0.11%
2024/05/15194.90294.3093.90-1952-0.11%
2024/05/141294.9800.0094.30121,0431.15%
2024/05/09193.8000.0093.3011,0720.09%
2024/05/03294.0000.0093.8021,3640.15%
2024/05/02194.0000.0094.9011,4140.07%
2024/04/2900.00694.2095.30-61,430-0.42%
2024/04/24090.80190.7090.70-11,455-0.07%
2024/04/1000.00199.6098.80-11,642-0.06%
2024/04/09198.0000.0097.6011,7220.06%
2024/04/03198.2000.0099.0011,7770.06%
2024/04/02299.4500.0098.9021,7800.11%
2024/04/0100.001100.5099.60-11,805-0.06%
2024/03/29198.400.299.0099.200.91,8130.05%
2024/03/27199.3000.0099.7011,8280.05%
2024/03/251101.5000.00101.0011,8160.06%
2024/03/2200.00296.0096.50-21,801-0.11%
2024/03/2100.00295.7096.00-21,827-0.11%
2024/03/19597.0000.0096.8051,8640.27%
2024/03/1800.00393.4093.30-31,855-0.16%
2024/03/14193.3000.0092.7011,8820.05%
2024/03/13192.3000.0092.4011,8960.05%
2024/03/1200.00295.8095.60-21,889-0.11%
2024/03/08298.10195.6095.1011,9240.05%
2024/03/07298.9000.0099.3021,9300.10%
2024/03/0600.00298.8098.10-21,937-0.10%
2024/03/0500.001101.50100.50-11,914-0.05%
2024/02/271105.004105.75103.00-31,995-0.15%
2024/02/2600.001.4102.79104.50-1.41,990-0.07%
2024/02/230.2101.502101.50101.00-1.81,981-0.09%
2024/02/221.2101.501101.50101.000.22,0180.01%
2024/02/2100.001.2102.58101.50-1.22,043-0.06%
2024/02/201.4100.671102.00101.500.42,0580.02%
2024/02/191102.0000.00101.5012,0750.05%
2024/02/166104.002104.50102.0042,0960.19%
2024/02/152111.001113.00110.5012,0600.05%
2024/02/0500.001106.50106.50-12,024-0.05%
2024/02/021105.501106.00105.5002,2160.00%
2024/02/012108.002107.50107.0002,2810.00%
智擎明、後年新藥將有斬獲 歐洲藥證+一期臨床數據結果Anue鉅亨-2023/11/03
智擎 相關文章